Maryland 2024 Regular Session

Maryland Senate Bill SB944

Introduced
2/2/24  
Refer
2/2/24  
Report Pass
3/15/24  
Engrossed
3/18/24  
Refer
3/19/24  
Report Pass
4/3/24  
Enrolled
4/5/24  
Chaptered
5/16/24  

Caption

Nonprescription Drugs and Devices - Provision by Registered Nurses and Sale of Contraceptives Through Automatic Devices

Impact

If enacted, SB944 would significantly amend existing laws concerning contraceptives, specifically eliminating restrictions on the sale of nonlatex and natural membrane condoms through automatic devices. It also allows registered nurses to provide various nonprescription drugs without a prescription, giving them more authority in public health contexts, such as addressing communicable diseases and family planning needs. The bill's proponents argue that these changes facilitate better access to essential health services.

Summary

Senate Bill 944 aims to enhance access to contraceptives and nonprescription drugs while authorizing registered nurses to dispense these items in local health departments. Specifically, the bill repeals prohibitions against the sale of certain contraceptives through vending machines, thereby expanding the means by which individuals can obtain such products. This change is intended to improve public access to contraceptive methods and increase reproductive health services available to the community.

Sentiment

The general sentiment regarding SB944 appears to be supportive among health advocates who believe that increasing access to contraceptives will lead to improved public health outcomes. However, there might be opposition from conservative groups who perceive the expanded availability of contraception and the role of nurses in dispensing drugs as a potential moral or ethical conflict, reflecting broader societal debates regarding reproductive rights and health access.

Contention

Notable points of contention may arise around the sale of contraceptives, particularly the use of vending machines in schools, which raises concerns about appropriateness and accessibility for minors. While the bill seeks to enhance public health access, it also faces scrutiny regarding the implications for educating young people about reproductive health. Additionally, potential pushback could emerge from discussions surrounding the responsibilities and scope of practice of registered nurses in dispensing medications.

Companion Bills

MD HB1171

Crossfiled Nonprescription Drugs and Devices – Provision by Registered Nurses and Sale of Contraceptives Through Automatic Devices

Previously Filed As

MD HB321

Cigarette Restitution Fund - Payments for Sale and Marketing of Electronic Smoking Devices - Use

MD SB64

HIV Prevention Drugs - Prescribing and Dispensing by Pharmacists and Insurance Requirements

MD HB966

Motor Vehicles - Modified Exhaust Systems and Noise Abatement Devices - Testing and Penalties

MD HB475

Advanced Practice Registered Nurse Compact

MD SB439

Advanced Practice Registered Nurse Compact

MD SB299

Grocery Stores and Restaurants - Automated External Defibrillator Program (Joe Sheya Act)

MD SB213

Health Occupations - Clinical Nurse Specialists - Prescribing

MD HB288

Grocery Stores and Restaurants - Automated External Defibrillator Program (Joe Sheya Act)

MD SB772

State Board of Nursing - Peer Advisory Committees, Scopes of Practice, and Licensure Requirements

MD SB888

Election Law - Automatic Voter Registration - Alterations

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

CA AB149

Controlled substances: prescriptions.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.